Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
Obesity continues to exist around the world despite the risk to health and death from illness and disease.
Read Full Newsvan Ingen, of Radboud University Medical Center discusses data showing add-on ALIS improved durable culture conversion in newly diagnosed MAC lung disease.
van Ingen, of Radboud University Medical Center, discusses the ENCORE trial's patient-reported endpoint for ALIS in MAC lung disease.
Vogelmeier, of Philipps-University of Marburg discusses pooled data showing reduced COPD exacerbations, though most effectively in former smokers.
Examining the Oral Steroid Burden in Asthma and COPD
Short Telomeres Linked to UIP Pattern, Not Fibrosis Extent, in ILD
CHEST 2026: Day 2 Recap — 4 Headlines to Know
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is biomarkers in multiple sclerosis!
1.
Research finds stark disparities in treatment and survival time for people with pancreatic cancer
2.
Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.
3.
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus
4.
Surviving cancer, still suffering: Survey reveals gaps in follow‑up care
5.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
1.
Immune Escape Landscapes in Solid Tumors
2.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
3.
Case Study: The Role of Machine Learning in the Detection of Skin Cancer
4.
Reconstruction of Surgical Defects After Cancer Resection
5.
Exercise Programming in Cancer Recovery: Evidence-Based Strategies for Clinical Practice
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge